BGLC
BioNexus Gene Lab Corp.
NASDAQ · Healthcare · Medical - Diagnostics & Research · MY
$1.57
+6.44%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$1.45
From 52W high−73.83%
Volume7320.00
Market cap$4.61M
P/E (TTM)—
P/S (TTM)1.5x
Div yield—
Key dataSep 18, 2026
Open
$1.45
From 52W high
−73.83%
Volume
7320.00
Market cap
$4.61M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.5x
P/E (TTM)
—
RSI (14)
47.1
MomentumView details →
1D Return
+6.44%
YTD Return
−62.53%
SummaryUpdated Jun 1, 2026
BioNexus Gene Lab Corp. (NASDAQ:BGLC) is a Malaysian-based company incorporated in 2017 and headquartered in Kuala Lumpur. The company went public on January 8, 2021, and operates through two primary subsidiaries across Southeast Asia. Originally focused on chemical raw materials distribution, BioNexus has been expanding into the medical diagnostics sector, positioning itself as a dual-business entity serving both industrial and healthcare markets in Malaysia, Indonesia, Vietnam, and other Southeast Asian countries.
Similar companies
Latest newsMore news →